Eriocitrin Inhibits Angiogenesis by Targeting VEGFR2-Mediated PI3K/AKT/mTOR Signaling Pathways
Nutrients · 08.04.2024 · 16 (7) · 1091
DOI: 10.3390/nu16071091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 08.04.2024. Verfasst von Ji-Yoon Baek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, The Graduate School of Dong-A University, Busan 49315, Republic of Korea. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Flavanones. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cooperative Research Program for Agriculture Science & Technology Development.
Abstract (Originalsprache)
Eriocitrin, a flavanone found in peppermint and citrus fruits, is known to possess many physiological activities. However, the anti-angiogenic effects of eriocitrin are yet to be fully elucidated. Therefore, the objective of this research was to explore the anti-angiogenic effects of eriocitrin both in vitro and in vivo as well as its underlying mechanism. Anti-angiogenic effects of eriocitrin were evaluated utilizing in vitro models of angiogenesis, including inhibition of tube formation, and induction of apoptosis in human umbilical vein endothelial cells (HUVECs). A chorioallantoic membrane (CAM) assay in chick embryos was also performed to evaluate the in vivo effects of eriocitrin on angiogenesis. Results showed significant eriocitrin effects on proliferation, tube formation, migration, and apoptosis in HUVECs. Furthermore, in vivo analysis revealed that eriocitrin significantly suppressed the formation of new blood vessels. In particular, it regulated MAPK/ERK signaling pathway and VEGFR2, inhibited the downstream PI3K/AKT/mTOR signaling pathway, and activated apoptosis signals such as caspase cascades. In HUVECs, the expression of matrix metalloproteinases (MMP-2 and MMP-9) exhibited an inhibitory effect on angiogenesis through the suppression of the signaling pathway. Therefore, eriocitrin presents potential for development into an antiangiogenic therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, The Graduate School of Dong-A University, Busan 49315, Republic of Korea.
- Department of Food Science and Nutrition, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.
- Center for Food & Bio Innovation, Dong-A University, Busan 49315, Republic of Korea.
ORCID-Profile: Ji-Yoon Baek, Mok-Ryeon Ahn
Förderung
- Cooperative Research Program for Agriculture Science & Technology Development
Zitieren
APA
Baek, J. Y., Kwak, J. E., & Ahn, M. R. (2024). Eriocitrin Inhibits Angiogenesis by Targeting VEGFR2-Mediated PI3K/AKT/mTOR Signaling Pathways. Nutrients, 16(7), 1091. https://doi.org/10.3390/nu16071091
Vancouver
Baek JY, Kwak JE, Ahn MR. Eriocitrin Inhibits Angiogenesis by Targeting VEGFR2-Mediated PI3K/AKT/mTOR Signaling Pathways. Nutrients. 2024;16(7):1091. doi:10.3390/nu16071091
BibTeX
@article{Baek2024,
author = {Baek, Ji-Yoon and Kwak, Jeong-Eun and Ahn, Mok-Ryeon},
title = {Eriocitrin Inhibits Angiogenesis by Targeting VEGFR2-Mediated PI3K/AKT/mTOR Signaling Pathways},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {7},
pages = {1091},
doi = {10.3390/nu16071091}
}
EUVIMED